Trial site
National Taiwan University Hospital NTUH
- 15running trials
- 5closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Gastric and oesophageal cancer2 trials
- Acute myeloid leukaemia1 trial
- Crohn's disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- High blood pressure1 trial
- IgA nephropathy1 trial
- Liver and biliary tract cancer1 trial
- Myelodysplastic syndromes1 trial
- Prostate cancer1 trial
- Stroke1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 39 trials
- Phase 26 trials
- Early phase 11 trial
- Phase 11 trial
- Status
- Active, not recruiting10 trials
- Recruiting5 trials
- Completed3 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Daiichi Sankyo6 trials
- Amgen2 trials
- Takeda2 trials
- A.Menarini Asia-Pacific Holdings Pte Ltd1 trial
- Alpine Immune Sciences Inc, A Subsidiary of Vertex1 trial
- and 8 more
Running trials
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Active, not recruiting
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Active, not recruiting
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Crohn's disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- High blood pressure1 recruiting
- Lung cancer1 recruiting
Closed trials
Completed
Clinical Decision Support System for Early Mobilization in the Neuro-ICU
Withdrawn
Completed
Completed
Terminated
Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)
Site data: ClinicalTrials.govUpdated 14 Nov 2026